An FDA document reveals that 86% of children between the ages of 12 and 15 who participated in Pfizer vaccine trials experienced adverse effects.

This troubling report, numbered 144413, only calls into question the use of the vaccine in children in that age range, approved on May 10 by the FDA, according to an FDA press release.

During the trials, 86% of the children had adverse reactions ranging from "mild" to "severe."

The results of the controversial experimentation can be viewed publicly in the document.

Table 5 Study 2: Frequency and percentages of adolescents with solicited local reactions, by maximum severity, within 7 days after each dose – Adolescents aged 12 to 15 years.

Source: fda.gov